glp 1 2024 Use of diabetes and anti-obesity drugs surges nationwide GLP-1 Receptor Agonist Market Size
Description
For people already managing appetite suppression or gastrointestinal changes on GLP-1 medications, this uncertainty matters
Real-World Trends in GLP-1 Treatment Persistence and Prescribing for Weight Management
Back Philipson, LH, Bell, G, Polonsky, KS (27 Jan 2015) 'Donald F
Most patients reach their target dose by week 20
The key practical difference: Wegovy has more dosing options for weight loss (up to 2.4 mg) and better access to manufacturer savings programs for uninsured patients
I was able to verify the Forbes claim by digging on my own
